Literature DB >> 21793043

Stem cell activation in adults can reverse detrimental changes in body composition to reduce fat and increase lean mass in both sexes.

Kristine M Wiren1, Joel G Hashimoto, Xiao-Wei Zhang.   

Abstract

Detrimental changes in body composition are often associated with declining levels of testosterone. Here, we evaluated the notion that multipotent mesenchymal stem cells, that give rise to both fat and muscle tissue, can play a significant role to alter existing body composition in the adult. Transgenic mice with targeted androgen receptor (AR) overexpression in stem cells were employed. Wild-type littermate and AR-transgenic male and female mice were gonadectomized and left untreated for 2 months. After the hypogonadal period, mice were then treated with 5α-dihydrotestosterone (DHT) for 6 weeks. After orchidectomy (ORX), wild-type males have reduced lean mass and increased fat mass compared to shams. DHT treatment was beneficial to partially restore body composition. In wild-type females, ovariectomy (OVX) produced a similar change but there was no improvement with DHT. In targeted AR transgenic mice, DHT treatment increased lean and reduced fat mass to sham levels. In contrast to wild-type females, DHT treatment in female transgenic mice significantly ameliorated the increased fat and decreased lean mass changes that result after OVX. Our results show that DHT administration reduces fat mass and increases lean mass in wild-type males but not females, indicating that wild-type females are not as sensitive to androgen treatment. Because both male and female transgenic mice are more responsive than wild-type, results suggest that body composition remains linked to stem cell fate in the adult and that targeted androgen signaling in stem cells can play a significant role to reverse detrimental changes in body composition in both sexes.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21793043      PMCID: PMC3202045          DOI: 10.1002/jcb.23288

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  46 in total

1.  Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Authors:  Christina Wang; Glenn Cunningham; Adrian Dobs; Ali Iranmanesh; Alvin M Matsumoto; Peter J Snyder; Thomas Weber; Nancy Berman; Laura Hull; Ronald S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

Review 2.  Bone stem cells.

Authors:  J E Aubin
Journal:  J Cell Biochem Suppl       Date:  1998

3.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

4.  Effects of combined estrogen/testosterone therapy on bone and body composition in oophorectomized women.

Authors:  A Flöter; J Nathorst-Böös; K Carlström; C Ohlsson; H Ringertz; B von Schoultz
Journal:  Gynecol Endocrinol       Date:  2005-03       Impact factor: 2.260

Review 5.  Testosterone, body composition and aging.

Authors:  A Vermeulen; S Goemaere; J M Kaufman
Journal:  J Endocrinol Invest       Date:  1999       Impact factor: 4.256

Review 6.  Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.

Authors:  Peter J Havel
Journal:  Curr Opin Lipidol       Date:  2002-02       Impact factor: 4.776

7.  Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters.

Authors:  Z Kalajzic; P Liu; I Kalajzic; Z Du; A Braut; M Mina; E Canalis; D W Rowe
Journal:  Bone       Date:  2002-12       Impact factor: 4.398

Review 8.  Androgens and body fat distribution.

Authors:  Karine Blouin; Ariane Boivin; André Tchernof
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-07       Impact factor: 4.292

Review 9.  Testosterone in obesity, metabolic syndrome and type 2 diabetes.

Authors:  R Stanworth; T Jones
Journal:  Front Horm Res       Date:  2009       Impact factor: 2.606

10.  Fat's loss is bone's gain.

Authors:  Liming Pei; Peter Tontonoz
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

View more
  2 in total

1.  Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes.

Authors:  Kristine M Wiren; Xiao-Wei Zhang; Dawn A Olson; Russell T Turner; Urszula T Iwaniec
Journal:  Bone       Date:  2012-08-14       Impact factor: 4.398

Review 2.  The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments.

Authors:  Varun S Venkatesh; Mathis Grossmann; Jeffrey D Zajac; Rachel A Davey
Journal:  Obes Rev       Date:  2022-01-27       Impact factor: 10.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.